Languages  By theme  By sector  By country
Page : 1 - 2 - 3 - 4 - 5 - 6 - 7 - 8 - 9 - ...
Hugo Boss AG [DE0005245534/BOS3]   
[15/07/2024]

Hugo Boss AG : EQS-Adhoc: HUGO BOSS AG: HUGO BOSS ANNOUNCES PRELIMINARY SECOND QUARTER RESULTS AND UPDATES ITS FULL-YEAR 2024 OUTLOOK

EQSAdhoc: HUGO BOSS AG / Key words: Quarter Results/Change in Forecast HUGO BOSS AG: HUGO BOSS ANNOUNCES PRELIMINARY SECOND QUARTER RESULTS AND UPDATES ITS FULLYEAR 2024 OUTLOOK 15Jul2024 / 22:58 CET/CEST Disclosure of an inside information acc. to Article 17 MAR of the Regulation EU No 596/2014, transmitted by EQS News a service of EQS Group AG. The issue... See more
 
CoTec Holdings Corp. [CA22165A1021/CTH]   
[15/07/2024]

CoTec Holdings Corp. : CoTec Holdings Corp. Grants Incentive Stock Options

VANCOUVER, BC / ACCESSWIRE / July 15, 2024 / CoTec Holdings Corp. TSXV:CTHOTCQB:CTHCF "CoTec" or the "Company" announces that the Company has granted a total of 532,301 stock options to an officer and director of the Company and a further aggregate 350,000 stock options together the "Options" to officers of the Company.The Options have an effective grant date of July... See more
 
Avant Brands Inc. [CA05353D1033/AVNT]   
[15/07/2024]

Avant Brands Inc. : Avant Brands Reports Continued Growth in Q2 2024 Financial Results

Record Gross Revenue: Generated $9.4 million in gross revenue, establishing a new company record.Strong International Growth: International sales rose 26% to reach a record $3.7 million, now representing 45% of net revenue.Record Cash Flow from Operations1: $4.6 million, highlighting the Companys ability to produce sustainable and growing cash flows.Record Adju... See more
 
ABIVAX [FR0012333284/ABVX]   
[15/07/2024]

ABIVAX : Abivax fournit une mise à jour opérationnelle et fait le point sur son programme clinique clé

Abivax fournit une mise à jour opérationnelle et fait le point sur son programme clinique clé • L’essai de phase 3 ABTECT évaluant Obefazimod dans la rectocolite hémorragique RCH modérément à sévèrement active, évolue favorablement pour achever le recrutement de patients au début du 1er trimestre 2025 • Les premiers résultats de l’essai d’induction... See more
 
ABIVAX [FR0012333284/ABVX]   
[15/07/2024]

ABIVAX : EQS-News: Abivax Provides Operational and Key Program Update

EQSNews: ABIVAX / Key words: Miscellaneous Abivax Provides Operational and Key Program Update 15.07.2024 / 22:00 CET/CEST The issuer is solely responsible for the content of this announcement. Abivax Provides Operational and Key Program Update Phase 3 ABTECT Trial evaluating obe... See more
 
ABIVAX [FR0012333284/ABVX]   
[15/07/2024]

ABIVAX : Abivax fournit une mise à jour opérationnelle et fait le point sur son programme clinique clé

ABIVAX Abivax fournit une mise à jour opérationnelle et fait le point sur son programme clinique clé 15Juil2024 / 22:00 CET/CEST Information réglementaire transmise par EQS Group. Le contenu de ce communiqué est de la responsabilité de l’émetteur.... See more
 
Canada Pharmacy [0]   
[15/07/2024]

Canada Pharmacy : B2B Pharmacy Services Now Available from Canada Pharmacy

Established Canadian online pharmacy now partnering with smaller pharmaciesVICTORIA, BC / ACCESSWIRE / July 15, 2024 / Logistic and operational challenges are increasingly the norm for businesses of all types, and notably so since the pandemic. Drug shortages may be less connected to the fallout from it, but they are a reality now for both consumers and the pharmacies that fill their... See more
 
SCOR [FR0010411983/SCR]   
[15/07/2024]

SCOR : SCOR provides an update on its Q2 2024 and FY 2024 results

Press release 15 July 2024 N° 10 SCOR provides an update on its Q2 2024 and FY 2024 results Following the negative experience variance in the first quarter of 2024, SCOR has decided to accelerate the annual L&H... See more
 
Page : 1 - 2 - 3 - 4 - 5 - 6 - 7 - 8 - 9 - ...
Videos
Gestionnaires,
Emetteurs,
My favourite companies
Most read news
Dissemination technology Webdisclosure.com - copyright 2024 SYMEX ECONOMICS all rights reserved